It’s been almost six months since PHASTAR opened the doors to its ninth office, based in Boston! The opening represented an important milestone in PHASTAR's history as its second office in the US and its first in the important Life Science Corridor of Massachusetts.
In that time, the office has grown to include a mixture of statisticians and programmers delivering PHASTAR’s award winning services to our ever-expanding US customer base, under the guidance of Director of Biostatistics Paul Stark.
To celebrate our time in Boston thus far, PHASTAR is hosting a networking and discussion evening in the Royal Sonesta Hotel, Cambridge, MA on Thursday 13th June from 6.30pm – 9.30pm. PHASTAR will be hosting talks from a leading pharma company, a joint RWE/CDM discussion as well as a talk from a global biotechnology company. The evening promises to be a celebration of all things life science!
All are welcome to come join us – pre booking is essential and tickets are available here https://bit.ly/2L17xzj
PHASTAR is delighted to be heading back to the far east, to exhibit at this years’ DIA Asia International Conference in Tokyo, Japan!
Exhibiting at stand I, PHASTAR’s Managing Director Andrew MacGarvey and Business Development Manager Edward Clark will be on hand over the two-day event to discuss PHASTAR’s award winning statistical consulting, clinical trial reporting and data management services. Running from 18th to 19th April, DIA Asia brings together some of the world’s most prominent figures in clinical development, medical affairs and CROs, to name a few.
Having made several trips to Japan in the past year including exhibiting at BIO Japan 2018 and a successful industry trip with JETRO this past February, PHASTAR is eager to increase its presence in Asia, which is fast becoming one of the worlds most important emerging regions in terms of drug development.
PHASTAR, the Cambridge based global CRO offering statistical consulting, clinical trial reporting and data management services is delighted to announce their sponsorship of the 2019 MassBio Annual Meeting, taking place on 27th – 28th at Royal Sonesta, Cambridge.
Focusing on the ‘State of Possible’, this year’s conference celebrates the advancements within the pharma and biotech industries and the possibilities these advancements offer the patients of today.
The MassBio conference attracts over 600 local and international pharma and biotech leaders, who over two days will discuss the challenges facing the life science industry and how to mitigate these.
PHASTAR, the global CRO offering statistical consulting, clinical trial reporting and data management services to the pharmaceutical and biotech industries, is delighted to be announced as winners of the inaugural award for Innovation in the Management of Clinical Data at this years ACDM Conference.
The annual awards were established in 2019 to further showcase the achievements in the management of clinical data of ACDM members, with winners being announced at the annual ACDM conference, this year taking place in Amsterdam.
Speaking on the win, Kevin Kane, CEO of PHASTAR, stated: “We at PHASTAR are delighted to be winners of this inaugural award in Innovation in the Management of Clinical Data. Our Data Management team’s number one focus is quality of work – we have a 100% success rate with our clients – and an innovative approach on handling data is one of the ways we ensure this. I am exceptionally proud of our data management team”.